{
    "data": [
        {
            "id": "4388036",
            "type": "article",
            "attributes": {
                "publishOn": "2020-11-12T06:00:00-05:00",
                "isLockedPro": false,
                "commentCount": 2,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "ResMed's Double-Digit Operating Leverage Is Offset By Valuation Risk",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105793",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "299984",
                            "type": "sentiment"
                        },
                        {
                            "id": "299985",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3545",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4388036-resmeds-double-digit-operating-leverage-is-offset-valuation-risk"
            }
        },
        {
            "id": "4367287",
            "type": "article",
            "attributes": {
                "publishOn": "2020-08-10T19:43:15-04:00",
                "isLockedPro": false,
                "commentCount": 2,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "ResMed: Premium Multiple Needs A Correction As Outlook Turns Gloomy",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "104895",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "287685",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3545",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4367287-resmed-premium-multiple-needs-correction-outlook-turns-gloomy"
            }
        },
        {
            "id": "4348330",
            "type": "article",
            "attributes": {
                "publishOn": "2020-05-17T20:10:57-04:00",
                "isLockedPro": false,
                "commentCount": 2,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "ResMed: Undervalued Despite A Two-Fold Impact From The Pandemic",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "104895",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "275876",
                            "type": "sentiment"
                        },
                        {
                            "id": "275877",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3545",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4348330-resmed-undervalued-despite-two-fold-impact-from-pandemic"
            }
        },
        {
            "id": "4327655",
            "type": "article",
            "attributes": {
                "publishOn": "2020-02-27T08:07:53-05:00",
                "isLockedPro": false,
                "commentCount": 0,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "ResMed Inc.: Competitive Bidding Clouds The Market Potential",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "104895",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "263054",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3545",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4327655-resmed-inc-competitive-bidding-clouds-market-potential"
            }
        }
    ]
}